LEGEND BIOTECH ($LEGN) posted quarterly earnings results on Tuesday, May 13th. The company reported earnings of -$0.07 per share, beating estimates of -$0.23 by $0.16. The company also reported revenue of $195,050,000, missing estimates of $197,066,274 by $-2,016,274.
You can see Quiver Quantitative's $LEGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LEGEND BIOTECH Hedge Fund Activity
We have seen 118 institutional investors add shares of LEGEND BIOTECH stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 4,357,503 shares (-39.0%) from their portfolio in Q4 2024, for an estimated $141,793,147
- SUVRETTA CAPITAL MANAGEMENT, LLC added 3,496,234 shares (+inf%) to their portfolio in Q4 2024, for an estimated $113,767,454
- CITADEL ADVISORS LLC added 1,588,303 shares (+120.6%) to their portfolio in Q4 2024, for an estimated $51,683,379
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) added 1,551,718 shares (+inf%) to their portfolio in Q4 2024, for an estimated $50,492,903
- GOLDMAN SACHS GROUP INC removed 1,469,440 shares (-59.0%) from their portfolio in Q1 2025, for an estimated $49,858,099
- BRAIDWELL LP added 1,436,400 shares (+93.2%) to their portfolio in Q4 2024, for an estimated $46,740,456
- WESTFIELD CAPITAL MANAGEMENT CO LP added 1,203,871 shares (+21.1%) to their portfolio in Q1 2025, for an estimated $40,847,343
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LEGEND BIOTECH Analyst Ratings
Wall Street analysts have issued reports on $LEGN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- H.C. Wainwright issued a "Buy" rating on 03/12/2025
- Johnson Rice issued a "Overweight" rating on 12/30/2024
To track analyst ratings and price targets for LEGEND BIOTECH, check out Quiver Quantitative's $LEGN forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
